Hengstman GJ - Search Results

1

Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up.

Hengstman GJ, van den Hoogen FH, van Engelen BG. Hengstman GJ, et al. Eur Neurol. 2004;52(1):61-3. doi: 10.1159/000079547. Epub 2004 Jul 5. Eur Neurol. 2004. PMID: 15240986 Clinical Trial. No abstract available.

2

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.

Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG. Hengstman GJ, et al. J Neurol. 2002 Jan;249(1):69-75. doi: 10.1007/pl00007850. J Neurol. 2002. PMID: 11954871

3

Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations.

Hengstman GJ, van den Hoogen FH, Barrera P, Netea MG, Pieterse A, van de Putte LB, van Engelen BG. Hengstman GJ, et al. Eur Neurol. 2003;50(1):10-5. doi: 10.1159/000070852. Eur Neurol. 2003. PMID: 12824706

4

Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate.

Hengstman GJ, De Bleecker JL, Feist E, Vissing J, Denton CP, Manoussakis MN, Slott Jensen H, van Engelen BG, van den Hoogen FH. Hengstman GJ, et al. Eur Neurol. 2008;59(3-4):159-63. doi: 10.1159/000114036. Epub 2008 Jan 29. Eur Neurol. 2008. PMID: 18230873 Clinical Trial.

5

Myositis during long-term interferon-alpha treatment.

Hengstman GJ, Vogels OJ, ter Laak HJ, de Witte T, van Engelen BG. Hengstman GJ, et al. Neurology. 2000 Jun 13;54(11):2186. doi: 10.1212/wnl.54.11.2186. Neurology. 2000. PMID: 10851394 No abstract available.

6

Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies.

van der Pas J, Hengstman GJ, ter Laak HJ, Borm GF, van Engelen BG. van der Pas J, et al. Among authors: hengstman gj. J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):136-9. J Neurol Neurosurg Psychiatry. 2004. PMID: 14707323 Free PMC article. Clinical Trial.

7

High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders.

Hengstman GJ, van Brenk L, Vree Egberts WT, van der Kooi EL, Borm GF, Padberg GW, van Venrooij WJ, van Engelen BG. Hengstman GJ, et al. J Neurol. 2005 May;252(5):534-7. doi: 10.1007/s00415-005-0683-5. Epub 2005 Feb 23. J Neurol. 2005. PMID: 15726253

8

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.

Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG. Hengstman GJ, et al. Ann Rheum Dis. 2006 Dec;65(12):1635-8. doi: 10.1136/ard.2006.052191. Epub 2006 May 5. Ann Rheum Dis. 2006. PMID: 16679430 Free PMC article.

9

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient.

Hengstman GJ, van Venrooij WJ, Vencovsky J, Moutsopoulos HM, van Engelen BG. Hengstman GJ, et al. Ann Rheum Dis. 2000 Feb;59(2):141-2. doi: 10.1136/ard.59.2.141. Ann Rheum Dis. 2000. PMID: 10666171 Free PMC article. No abstract available.

10

[The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time].

Hengstman GJ, van Venrooij WJ, van den Hoogen FH, van Engelen BG. Hengstman GJ, et al. Ned Tijdschr Geneeskd. 2003 Aug 2;147(31):1485-9. Ned Tijdschr Geneeskd. 2003. PMID: 12924076 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters